BioPharmSignal logoBioPharmSignal

Biotech News

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NEXGEL (NXGL)NEXGELCompany update

NXGL (NXGL) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is nxgl.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

NXGLNEXGEL2026-05-06 13:00 EST

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NXGLNEXGEL2026-04-27 13:00 EST

NEXGEL Appoints Ian Blackman as Chief Financial Officer

View all latest news

NEXGEL

Hydrogel and Healthcare Products Company NEXGEL develops, manufactures, and commercializes healthcare, beauty, and over-the-counter products. Its core expertise is in soft, high-water-content hydrogels used in wound care, skin care, consumer health, and other applications requiring gentle contact with the body. Cross-Linked Hydrogel...

Recent company news

NXGLNEXGEL2026-09-16 13:29 EST

NEXGEL Announces Date for Investor Update Call

NXGLNEXGEL2026-08-20 20:05 EST

NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE

NXGLNEXGEL2026-08-17 12:00 EST

NEXGEL Reports Second Quarter 2026 Financial Results

NXGLNEXGEL2026-06-04 13:00 EST

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NXGLNEXGEL2026-05-19 13:00 EST

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

Stock data

Close
0.28 USD
Market cap
5.31M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States